Canadian Bioceutical Corporation (BCC) has announced plans to expand its life sciences business into the production, processing and distribution of medical marijuana and cannabis based medical products, and that, as soon as the company receives its license from Health Canada, it intends to commence operations of its newest venture in Owen Sound’s industrial park.
The facility will occupy 155,000 sq. ft and is expected to be one of the largest facilities in North America. It will have state of the art production capability, laboratory encapsulation and packaging capabilities. Once fully operational, it is expected to employ up to 100 full time employees.
The City has always been open to new business and new ideas, and this is no exception. “I welcome BCC as our newest manufacturer and a major new employer”, says Mayor Ian Boddy. I congratulate Peter Van Dolder and the ownership group of the Peninsula Pro-Growth Business Park (former PPG building) for revitalizing the building and making it possible to attract new
manufacturers like BCC.”
Medical marijuana production and distribution is a regulated industry and licensed by Health Canada. It is a highly controlled medical production process that will be required to meet numerous security and safety production criteria as determined by Health Canada and the
provincial government.
Source: City of Owen Sound Economic Development
More on Canadian Bioceutical Corporation
BCC, formerly Allegiance Equity Corporation, is an Ontario corporation that, for over two decades has been developing unique standardized mass-market nutraceutical products for the treatment of common ailments where present pharmaceutical treatments and Over-the-Counter (OTC) products fail to meet the needs of patients. BCC has targeted markets having clearly identified product deficiencies and dissatisfied consumers afflicted with a variety of medical conditions. BCC obtains regulatory approval and patents for these unique compounds and formulations and may produce and distribute or license its products for royalty revenues.
BCC’s principal brands are CinG-X(TM) and Relieva(TM) and the company, through its subsidiary BioCannabis Products Ltd., will shortly be launching a series of cannabis-based branded products to address this rapidly-evolving market.
Source: Accesswire
